Auxilius provides cloud-based clinical trial financial management (CTFM) software that addresses the unique operational, financial, and accounting needs of clinical trials. The company's platform allows biotechs and pharmaceutical companies to streamline core FP&A and accounting workflows, hold outsourced vendors accountable through change, and establish processes supporting audit, compliance, and reporting requirements. Auxilius' software integrates disparate clinical, contractual, and financial data, enabling sponsors to manage trial costs, clinical vendors, and financial risks and optimize spending toward trial targets. The platform supports functions such as budgeting, planning, and financial closing.
Key customers and partnerships
Auxilius caters to a diverse range of customers, from private biotechs running individual Phase I studies to mature, public biopharma firms operating dozens of complex global trials, collectively managing billions in clinical R&D spend.
The company noted that, as of July 2024, it had helped manage over 120 sites, 95+ vendors, and managed over USD 2 billion in clinical study spending. The company also noted that it had worked with life science and clinical trial audit companies such as INVIVYD, mati Therapeutics, FRACTYL health, X4 Pharmaceuticals, Apellis, Applied Therapeutics, PMV Pharma, and Travere Therapeutics.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.